Longevity by Design

Dr. Daniel Durand, Chief Medical Officer at Prenuvo and a pioneer in radiology innovation, shares his insights on the transformative power of whole-body MRI in preventative health. He explains how this technology offers non-invasive, radiation-free scans that redefine early cancer detection. The conversation tackles misconceptions around overdiagnosis and highlights how AI in imaging can improve accuracy and reduce unnecessary procedures. Dr. Durand envisions a future where personalized data empowers patients to prioritize prevention over treatment.

Dr. Eran Segal, a Professor at the Weizmann Institute of Science, specializes in AI and personalized medicine. He discusses how AI and machine learning are reshaping nutrition and healthcare, emphasizing the need for robust data to enhance personalized health solutions. Eran envisions AI-powered digital twins for simulating lifestyle impacts on health, while cautioning against over-reliance on technology. He underscores that foundational habits like good nutrition, sleep, and exercise remain vital for longevity, showing that technology must work hand in hand with basic healthy choices.

Discover the potential of GLP-1 agonists, originally created for diabetes, now revolutionizing weight management and longevity. Learn how these drugs affect appetite, metabolism, and heart health. The conversation also explores the benefits of wearable tech like Apple Watch and Oura Ring, which enhance health tracking and fall prevention, particularly in older adults. With insights on personalized health strategies and the future of medical devices, this discussion emphasizes informed decision-making for better longevity and wellness.

Dr. Gabrielle Lyon, a board-certified family physician and bestselling author, discusses the alarming rise of sarcopenia and the impact of GLP-1 medications on muscle loss. She emphasizes the importance of muscle as a metabolically active organ crucial for longevity and introduces the concept of 'muscle span.' The conversation dives into dietary protein, advocating for higher intake for healthy aging, and addresses misconceptions about hormone replacement therapy. Lyon offers actionable insights to prioritize muscle health and enhance overall well-being.

On this episode of Longevity by Design, Dr. Gil Blander speaks with Dr. Michael Ringel, COO of Life Biosciences, about the science of aging and longevity. Michael discusses how evolution influences lifespan and why aging occurs. He explains the trade-off between resource allocation for reproduction versus maintenance and repair within the body. Caloric restriction and its effects on lifespan are explored through an evolutionary lens.Michael highlights the challenges and breakthroughs in longevity research. He touches upon the role of genetics and pharmaceuticals in manipulating lifespan and healthspan. He points to the Pacific rockfish as an example of varying lifespans within a closely related group of species, demonstrating the genetic component of aging. He also notes the impact of Cell reprogramming, referencing a study on how specific Cell reprogramming can regenerate optic nerves.The conversation shifts to the business of longevity, where Michael discusses the increased interest and investments from big pharma and billionaires. He examines the economic benefits of extending healthspan, citing a potential value of $300 trillion from a 10-year healthspan extension in the US alone. Michael and Gil also explore the importance of lifestyle choices for healthy aging, emphasizing diet, exercise, sleep, stress management, and social connections.Guest-at-a-Glance💡 Name: Dr. Michael Ringel 💡What they do: COO💡Company: Life Biosciences💡Noteworthy: Biotechnology COO bridging science and business for longevity breakthroughs.💡 Where to find them: LinkedIn   Episode highlights:[00:00:56] Meet Dr. Michael Ringel[00:02:30] Journey to Becoming a Scientist[00:04:26] Interest in Longevity and Aging[00:07:59] Evolution and Aging[00:21:04] Caloric Restriction and Lifespan[00:25:07] InsideTracker: Personalized Healthspan Optimization[00:26:02] Pharma's Role in Aging Research[00:37:32] Understanding Causality in Medical Research[00:38:09] Challenges of Observational Studies[00:39:40] Experimental Studies and the TAME Trial[00:40:21] Pharmaceutical Incentives and Metformin[00:40:56] Exploring Rapalogs and Patent Issues[00:43:39] Hallmarks of Aging and Future Prospects[00:45:59] Investment in Aging Research[00:52:35] Economic and Social Impacts of Longevity[01:02:30] Practical Tips for Extending Lifespan For science-backed ways to live a healthier longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

In this engaging discussion, Dr. S. Jay Olshansky, a professor specializing in aging and biodemography, sheds light on the biological limits of human longevity. He reveals how advancements in public health have dramatically increased life expectancy, yet gains are slowing. The conversation dives into the intricate relationship between genetics and lifestyle choices, as well as societal factors affecting longevity. Dr. Olshansky emphasizes the importance of sustainable health practices over pharmaceutical fixes, offering practical tips for enhancing both lifespan and healthspan.

Can personalized medicine unlock the secrets to living longer and healthier lives? In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. David Barzilai, a renowned longevity physician and founder of Barzilai Longevity Consulting, to explore the science of extending healthspan through precision and innovation.Dr. Barzilai shares his journey into biogerontology and longevity science, unpacking key concepts like the hallmarks of aging, the potential of lifestyle interventions, and the translation of findings from animal models to human health. He highlights how evidence-based lifestyle medicine—centered on nutrition, exercise, sleep, and stress management—can be tailored to individual needs using biomarker-driven strategies for maximum impact.The conversation delves into some of the most promising longevity interventions, from gerotherapeutics to cutting-edge supplements. Dr. Barzilai emphasizes the power of personalized approaches in optimizing healthspan and lifespan, offering listeners practical, science-backed insights to take charge of their longevity journey.Engaging and informative, this episode is essential listening for anyone curious about the future of longevity medicine and the innovations shaping how we age. Guest-at-a-Glance💡 Name: Dr. David Barzilai, MD, PhD💡What he does: Founder and CEO💡Company: Healthspan Coaching LLC💡Noteworthy: Renowned longevity physician integrating science and personalized health strategies.💡 Where to find them: LinkedIn, Twitter  Episode highlights:Introduction: 00:00:00Dr. Barzilai’s Journey into Science: 00:03:43The Importance of Translating Science into Practice: 00:10:00The Role of Social Media in Longevity Science: 00:16:37Defining Biogerontology: 00:22:32Understanding the Hallmarks of Aging: 00:24:27The Role of Lifestyle Medicine in Preventing Premature Mortality: 00:36:13Caloric Restriction and Its Effects on Lifespan: 00:37:33Human Trials and the Challenges of Compliance: 00:41:13The Potential of Rapamycin and mTOR Inhibitors: 00:42:05The Importance of Lifestyle Medicine: 00:51:25Precision Medicine: Tailoring Health Interventions: 01:02:56GLP-1 and Alcohol Absorption: 01:12:30Exercise and Mortality Reduction: 01:15:33Biomarkers and Metabolic Health: 01:19:38Longevity Drugs and Supplements: 01:25:43Epigenetic Reprogramming and Aging: 01:45:06For science-backed ways to live a healthier longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

Dr. Dmitriy Richard Starson, Founder and CEO of Passio, discusses his fascinating journey from astrophysics to creating an AI nutrition coaching platform. He details how Passio's technology revolutionizes food tracking through AI-driven tools like food scanning and voice logging. Dmitriy envisions a future where personalized nutrition is as common as fitness tracking, potentially slowing aging. He addresses the importance of accurate dietary data and the synergy between AI and human expertise in enhancing health outcomes.

In this episode of Longevity by Design, our host Dr. Gil Blander welcomes Dr. Aubrey de Grey, a biomedical gerontologist, to explore the frontiers of aging research and lifespan extension. Dr. de Grey shares his work identifying and addressing the seven major categories of aging-related diseases. He discusses how targeted damage repair offers a promising alternative to traditional methods to slow aging, providing a path to longer, healthier lives.The conversation delves into the hallmarks of aging, their implications for medical research, and the challenges of translating results from animal models to human applications. Dr. de Grey emphasizes the importance of combining multiple interventions, such as senolytics, gene therapy, and stem cell treatments, to achieve significant gains in lifespan. He also shares insights from his work with the LEV Foundation and the Methuselah Foundation.Listeners will gain a deeper understanding of the science behind rejuvenation and the potential for humanity to reach longevity escape velocity within the coming decades. Dr. de Grey underscores the critical role of continued research, innovation, and funding in accelerating progress toward defeating aging-related diseases. Episode highlights:Introduction: 00:00:00The Seven Hallmarks of Aging: A Foundational Framework: 00:07:00Challenges in Funding Longevity Research: 00:15:00Lifestyle, Genetics, and the Limits of Current Longevity: 00:23:00The Methuselah Foundation and Early Longevity Advocacy: 00:37:00Top tip to improve healthspan: 00:52:00We Appreciate You!As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcastFor science-backed ways to live a healthier longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

On this episode of Longevity by Design, Dr. Gil Blander welcomes Dr. John Erdman to discuss prostate cancer and the impact of diet on disease progression. John shares his personal connection to this disease and why he’s dedicated his research to understanding dietary interventions.John explains that prostate cancer is often slow-growing, with most men experiencing decades between early mutations and noticeable tumor growth. He stresses the importance of early detection through regular checkups, including digital exams and PSA tests. While the medical community debates the effectiveness of these tests, John advocates for establishing a baseline to monitor for any sudden changes.John's research reveals a strong link between tomato consumption and reduced prostate cancer risk. He believes this protective effect stems from lycopene and its metabolites, which may influence gene expression. John emphasizes that while tomato consumption shows promise, maintaining a healthy weight and regular exercise are equally crucial for long-term health. Episode highlights:Introduction: 00:00:00The Stages and Progression of Prostate Cancer: 00:06:00Diagnosing Prostate Cancer: Methods and Considerations: 00:11:00The Role of Specific Foods in Prostate Cancer Risk Reduction: 00:22:00Exploring the Link Between Gut Microbes and Prostate Cancer: 00:30:00Top tip to improve healthspan: 00:34:00For science-backed ways to live a healthier longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast